Albrecht Poth

From in vivo to in vitro: The medical device testing paradigm shift.

Thomas Hartung, Dayna Kerecman Myers, Alan M Goldberg, 2017, ALTEX.

Utility of a multidimensional evaluation scheme for nano scale materials

John Handley, Albrecht Poth, Tetsuo Sato, 2012 .

Alternative testing : The intelligent way to REACH compliance

Albrecht Poth, A. Poth, 2009 .

Worldwide Trend in Nanomaterial Safety Evaluation

Albrecht Poth, Tetsuo Satoh, Takayuki Anzai, 2012 .

Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010

Valérie Zuang, George Loizou, Andrew Worth, 2011, Archives of Toxicology.

Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.

Albrecht Poth, Cyrille Krul, Maya R Vilà, 2012, Toxicology in vitro : an international journal published in association with BIBRA.

Fate of micronuclei and micronucleated cells.

Helga Stopper, Albrecht Poth, Henning Hintzsche, 2017, Mutation research.

Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs

Paul L. Carmichael, Albrecht Poth, Leonard M. Schechtman, 2011, Mutagenesis.

Bhas42 cell transformation assay as a predictor of carcinogenicity

Albrecht Poth, A. Poth, Susanne Bohnenberger, 2008 .

State of the art on alternative methods to animal testing from an industrial point of view: ready for regulation?

Albrecht Poth, Cyrille Krul, Erwin L Roggen, 2014, ALTEX.

Genetic toxicity assessment: employing the best science for human safety evaluation part IV: Recommendation of a working group of the Gesellschaft fuer Umwelt-Mutationsforschung (GUM) for a simple and straightforward approach to genotoxicity testing.

Albrecht Poth, Silvio Albertini, Stefan Pfuhler, 2007, Toxicological sciences : an official journal of the Society of Toxicology.